Lupin Management Speaks On The Co's Q4FY23 Earnings & India And US Biz Updates | Halftime Report

Lupin Management Speaks On The Co's Q4FY23 Earnings & India And US Biz Updates | Halftime ReportПодробнее

Lupin Q4 Beats Street Estimates | India Growth Aids Q4 Margins | CEO Vinita Gupta | Business NewsПодробнее

Lupin Q4FY23 Earnings Tomorrow: Here are key expectations | NSE Closing Bell |CNBC-TV18Подробнее

Lupin MD, CEO and CFO with ET Now – Q1 FY24 Earnings – 7 August 2024Подробнее

Lupin Q1: India Biz Returns To Double Digit Growth | Lupin Management On Q1 Numbers | Business NewsПодробнее

US Biz Impacted QoQ Due To Phasing Of Launches, Optimistic On India Growth Momentum: LupinПодробнее

CNBC-TV18 LIVE | Lupin Ltd Reports Q4 Earnings | Earnings CentralПодробнее

Lupin's Management Talks About The Company's Q2FY Results | Halftime Report | CNBC-TV18Подробнее

Lupin Management with CNBC TV18 on the Q4 FY23 earningsПодробнее

Lupin MD, CEO and CFO with CNBC TV18 – Q1 FY24 Earnings – 7 August 2024Подробнее

Lupin's MD, CEO and CFO on ET NOW on the Q1 FY2024 Earnings 04 Aug 2023Подробнее

Lupin's MD, CEO and CFO with CNBC TV18 – Q4 FY24 Earnings – 7 May 2024Подробнее

Lupin Shares Rise Post Reporting Good Q4 Results, Margin Expands To 7-Quarter High | CNBC-TV18Подробнее

Five Things You Need To Know About Lupin Q4 EarningsПодробнее

Lupin MD, CEO and CFO with CNBC TV18 – Q2 FY25 Earnings – 7 November 2024Подробнее

Live Oak Bancshares (LOB|$1.8B) - 2024 Q4 Earnings AnalysisПодробнее

Lupin's performance will come back to 'levels of normalcy' in FY 22-23, says CFOПодробнее

Stock watch: Lupin zooms 4% after receiving gSpiriva approval from USFDAПодробнее

Lupin’s Kamal Sharma On Its Poor Q4 Numbers, Below Industry EstimatesПодробнее

Indian pharma Lupin's biggest market is also its biggest challenge, says MDПодробнее